bluebird bio Inc
(NAS:BLUE)
$
0.405
0.0272 (7.2%)
Market Cap: 78.75 Mil
Enterprise Value: 376.50 Mil
PE Ratio: 0
PB Ratio: 0
GF Score: 31/100 bluebird bio Inc at Canaccord Genuity Growth Conference (Virtual) Transcript
Aug 12, 2020 / 02:30PM GMT
Release Date Price:
$39.99
(-1.14%)
John Lawrence Newman
Canaccord Genuity Corp., Research Division - Principal & Senior Healthcare Analyst
Welcome to the 40th Annual Canaccord Genuity Growth Conference held virtually this year. I'd like to welcome bluebird bio, who I'm sure everyone knows. Here to tell us more about the company today are the CEO, Nick Leschly; and the Chief Scientific Officer, Dr. Philip Gregory.
So Nick and Philip, welcome, and thanks very much for joining us today.
Questions & Answers
John Lawrence Newman
Canaccord Genuity Corp., Research Division - Principal & Senior Healthcare Analyst
I wonder if you could start by talking to us about the resubmission of ide-cel for relapsed/refractory multiple myeloma. It's great to see that, that's done now. Could you give us any details on the CMC portion? Or maybe just speak generally about the issues that were successfully addressed.
Nick Leschly
bluebird bio, Inc. - President, CEO & Director
Yes. Thank you. This is Nick talking, so people can recognize
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot